Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2022 | Role of perioperative therapy in colon cancer

Alvaro Arjona-Sanchez • 11 Oct 2022
ESMO 2022
Colorectal Cancer Gastrointestinal Cancer

Alvaro Arjona-Sanchez, MD, Reina Sofia University Hospital, Córdoba, Spain, outlines the role of perioperative therapy in colorectal cancer, highlighting the role of HIPEC and mitomycin C. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Alvaro Arjona-Sanchez

0:39
Laparoscopic approach vs open surgical approach for colon cancer
Alvaro Arjona-Sanchez • 11 Sep 2022
0:46
Treatment landscape for colon cancer
Alvaro Arjona-Sanchez • 11 Oct 2022
0:48
Adjuvant HIPEC in locally advanced colon cancer
Alvaro Arjona-Sanchez • 11 Sep 2022

Related Videos

1:53
Important pathophysiological determinants of elevated cirDNA post-surgery
Alain Thierry • 9 Apr 2024
0:47
Emerging molecular drivers and biomarker targets in gastroesophageal cancers
Tatsuhiro Shibata • 9 Apr 2024
0:52
DRP-104 with durvalumab in fibrolamellar hepatocellular carcinoma
Marina Baretti • 9 Apr 2024
1:06
The emerging role of cancer vaccines in treating liver cancer
Marina Baretti • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals